David Kirn - Net Worth and Insider Trading

David Kirn Net Worth

The estimated net worth of David Kirn is at least $9 Million dollars as of 2024-11-05. David Kirn is the CEO of 4D Molecular Therapeutics Inc and owns about 1,059,153 shares of 4D Molecular Therapeutics Inc (FDMT) stock worth over $9 Million. Details can be seen in David Kirn's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that David Kirn has not made any transactions after 2024-07-10 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of David Kirn

To

David Kirn Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, David Kirn owns 1 companies in total, including 4D Molecular Therapeutics Inc (FDMT) .

Click here to see the complete history of David Kirn’s form 4 insider trades.

Insider Ownership Summary of David Kirn

Ticker Comapny Transaction Date Type of Owner
FDMT 4D Molecular Therapeutics Inc 2024-07-10 director & Chief Executive Officer

David Kirn Latest Holdings Summary

David Kirn currently owns a total of 1 stock. David Kirn owns 1,059,153 shares of 4D Molecular Therapeutics Inc (FDMT) as of July 10, 2024, with a value of $9 Million.

Latest Holdings of David Kirn

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
FDMT 4D Molecular Therapeutics Inc 2024-07-10 1,059,153 8.18 8,658,576

Holding Weightings of David Kirn


David Kirn Form 4 Trading Tracker

According to the SEC Form 4 filings, David Kirn has made a total of 8 transactions in 4D Molecular Therapeutics Inc (FDMT) over the past 5 years, including 0 buys and 8 sells. The most-recent trade in 4D Molecular Therapeutics Inc is the sale of 12,923 shares on July 10, 2024, which brought David Kirn around $290,638.

Insider Trading History of David Kirn

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

David Kirn Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

David Kirn Ownership Network

Ownership Network List of David Kirn

No Data

Ownership Network Relation of David Kirn

Insider Network Chart

David Kirn Owned Company Details

What does 4D Molecular Therapeutics Inc do?

Who are the key executives at 4D Molecular Therapeutics Inc?

David Kirn is the director & Chief Executive Officer of 4D Molecular Therapeutics Inc. Other key executives at 4D Molecular Therapeutics Inc include Chief Legal and HR Officer Scott Bizily , Chief Medical Officer Robert Young Kim , and 10 percent owner Viking Global Investors Lp .

4D Molecular Therapeutics Inc (FDMT) Insider Trades Summary

Over the past 18 months, David Kirn made 5 insider transaction in 4D Molecular Therapeutics Inc (FDMT) with a net sale of 225,853. Other recent insider transactions involving 4D Molecular Therapeutics Inc (FDMT) include a net sale of 39,883 shares made by Scott Bizily , a net purchase of 310,000 shares made by Viking Global Investors Lp , and a net sale of 24,552 shares made by Robert Young Kim .

In summary, during the past 3 months, insiders sold 1,000 shares of 4D Molecular Therapeutics Inc (FDMT) in total and bought 0 shares, with a net sale of 1,000 shares. During the past 18 months, 830,288 shares of 4D Molecular Therapeutics Inc (FDMT) were sold and 850,000 shares were bought by its insiders, resulting in a net purchase of 19,712 shares.

4D Molecular Therapeutics Inc (FDMT)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

4D Molecular Therapeutics Inc Insider Transactions

No Available Data

David Kirn Mailing Address

Above is the net worth, insider trading, and ownership report for David Kirn. You might contact David Kirn via mailing address: C/o 4d Molecular Therapeutics Inc., 5858 Horton Street #455, Emeryville Ca 94608.